A medical device company improving surgical oncology
Fairway Biomed was founded out of Washington University in St. Louis when cofounders Jeff Chininis and Chet Hammill began collaborating in the Summer of 2017. The company focusses on medical devices to improve surgical oncology. Our first device, the LIVO, better controls bleeding in resection surgeries to remove tumors in the liver, kidney, and lung. This potentially life saving technology is in its preclinical R&D phase and we are raising a Seed Round of funding to begin FDA clearance testing.
Jeff Chininis, MEng
Chininis holds a Bachelor of Science in Bioengineering and a Master of Engineering in Biomedical Innovation. The Biomedical Innovation program at Washington University in St. Louis specifically trains students to lead a medical device venture. Additionally, Jeff has been trained through the Missouri ICORPS program, Wash U’s Olin Business School’s Business Planning for New Enterprises training program, and work with the Skandalaris Center for Innovation and Entrepreneurship.
Chet Hammill, MD
Hammill is serving as Chief Medical Officer and is a graduate of the University of Illinois College of Medicine. He provides 15 years expertise as a hepatobiliary and pancreas surgeon, having performed over 1,000 liver resections. He is on the American Board of Surgery and is a Fellow of the American College of Surgeons. He has been affiliated with the Providence Portland Medical Center and recently Barnes Jewish Hospital, a worldwide leader in cancer treatments.